Corden Pharma - A Full-Service CDMO’s Post

#EliLilly has acquired #NexusPharmaceuticals' #Wisconsin #facility to expand its #injectablemedicine production capacity. With FDA approval expected by 2025, this move aligns with Lilly's commitment to meeting growing demand for their medicines, particularly #GLP-1 drugs like #Mounjaro and #Zepbound. Recent reports of supply constraints underscore the urgency for increased production, prompting Lilly's strategic investments in manufacturing facilities and partnerships with CDMOs like #Catalent #NationalResilience, and #BSPPharmaceuticals. Since #Catalent's #acquisition by #NovoHoldings (fellow GLP-1 developer #NovoNordisk’s investment arm) came to light Lilly has been concerned about potential disruptions in their supply chain. Thus Lilly can be seen bolstering its manufacturing capacity through acquisitions and partnerships. #Biopharma #Manufacturing #GLP1 #Expansion #Innovation #acquisition

Exciting news from Vetter once again! The company has earned the 2024 CDMO Leadership Awards in all six core categories, reaffirming its commitment to excellence in the pharmaceutical and biotech industries. Congratulations to the entire Vetter team, including Managing Director Peter Soelkner, for this outstanding achievement! Vetter's dedication to embodying award-winning characteristics underscores their commitment to delivering the best to customers and patients, leveraging decades of experience and expertise. Surpassing the one billion sales threshold reflects Vetter's strong commitment to stable customer relationships and sustainable growth, highlighting their position as a trusted partner in the industry. As drug owners increasingly rely on CDMOs for supply chain stability and proven processes, how can companies ensure they are selecting the right partner to meet their development, manufacturing, and packaging needs? #PharmaIndustry #CDMOs #BusinessPartnerships #CDMO #LeadershipAwards #Pharma

Roche's Transformational Journey: Missing the Secret Ingredient? Most transformations falter without balanced leadership support! Join Bill Anderson, previous CEO of Roche Pharmaceuticals, and Michael Lurie as they share a groundbreaking transformation: 💡 Balancing Top-Down and Bottom-Up Leadership 💡 Customer-Centricity: Making Field Voices Heard 💡 Vital Framework: Setting Priorities for Success 💡 Organic Growth: 400 Agile Coaches by Employee Initiative Discover the secrets behind Roche’s impressive 25-100% productivity boost and agile transformation! 📹 https://lnkd.in/dFTDcwvU #Talk #eXperienceAgile #WorldManagementAgilityForum #RocheTransformation #Agility #Leadership #BusinessInnovation #Productivity #Pharmaceuticals #OrganizationalChange

What can the Executive Vice President of Development & Research at the international company Servier teach us about leadership? Dr Claude Bertrand has worked with many pharmaceutical giants, including AstraZeneca, Pfizer, Roche and Ipsen. He is an extraordinary leader with many insights into the fascinating pharmaceutical industry. Together, with our CEO, Thom Dennis, they explore the responsibility of leaders, the crucial leadership traits to hone and the significance of purpose. >> https://lnkd.in/eteMYf7v #pharmaceuticalindustry #leadership #leadershipdevelopment #podcast #executiveleaders

🎉 Leadership Update: Bhushan Akshikar Appointed as OPPI President 🎉 Exciting news in the pharma industry! Bhushan Akshikar has been appointed as the new President of the Organisation of Pharmaceutical Producers of India (OPPI). With years of industry experience, his leadership promises to guide OPPI toward new growth and innovation in healthcare. Read more about this key appointment and its impact on the industry: Sushmita Panda Sakshi Kuchroo Sumana Sarkar Roshun Povaiah Syed Fazal Bari E Kumar Sharma #Pharma #Leadership #Healthcare #OPPI #BhushanAkshikar #PharmaIndustry #HealthcareNews

Everyone must attend this powerful session! This will provide clarity to choose your future pharmaceutical domain with respect to your skill set.

'Leadership is not about being in charge. It's about taking care of those in your charge." - Simon Sinek In pharmaceutical marketing, caring for your team means providing them with the tools and support they need to succeed. Together, we can create impactful campaigns that improve patient outcomes. #Leadership #PharmaMarketing #Teamwork #SimonSinek #PatientOutcomes #neomarketer

Honored to share that I have successfully completed the #Insights Management workshop, a key component of the CMSL Advance Program, provided by the Academy Of Pharmaceutical Affairs - APA. The #Insights and strategies learned will be invaluable as I continue to navigate the complexities of #MedicalAffairs. Looking forward to implementing these skills to deliver impactful results. #MedicalAffairs #CMSL #AdvanceProgram #Leadership

Our latest #CMI #Newsletter is out now! Contract development and manufacturing organizations (CDMOs) are integral to #the pharmaceutical value chain, having emerged as prominent players and trusted business partners in meeting a growing demand for innovative medicines and adaptable solutions. Over the past three decades, the #CDMO industry transformed significantly, prompting a recalibration of leadership requirements. Are existing structures and leadership expertise equipped to navigate the complexities of the CDMO business and guide organizations successfully through #transformation? A recent survey investigated the current state of leadership within CDMOs, examining both executive leadership and board levels, and its implications for organizational success. Read more about this topic and about company news from AbbVie, The Chemours Company, Daiichi Sankyo US, Exscientia, H.B. Fuller, Honeywell, Manuchar, MSD, Pfizer, Recursion, SNF, Symrise AG, and more in our newsletter: https://lnkd.in/ekaP6aVw

Finding and working successfully with rare disease key opinion leaders is a must-do but how do you do it? Work at a pharmaceutical company and want to share your thought leadership? Get in touch to take part in a virtual interview to contribute to a FirstWord Expert View report. #MedicalAffairs #KOLs #Raredisease